Phoenix Financial’s Alexion Pharmaceuticals Inc ALXN Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2021
Q3 | – | Sell |
-162,858
| Closed | -$29.9M | – | 449 |
|
2021
Q2 | $29.9M | Buy |
162,858
+2,242
| +1% | +$412K | 0.57% | 64 |
|
2021
Q1 | $24.6M | Sell |
160,616
-24,087
| -13% | -$3.68M | 0.56% | 61 |
|
2020
Q4 | $28.8M | Buy |
+184,703
| New | +$28.8M | 0.77% | 52 |
|
2020
Q3 | – | Sell |
-254,703
| Closed | -$27.1M | – | 374 |
|
2020
Q2 | $27.1M | Buy |
254,703
+40,000
| +19% | +$4.26M | 1.15% | 23 |
|
2020
Q1 | $18.8M | Buy |
214,703
+40,000
| +23% | +$3.51M | 0.95% | 32 |
|
2019
Q4 | $18.8M | Sell |
174,703
-18,230
| -9% | -$1.96M | 0.78% | 57 |
|
2019
Q3 | $18M | Buy |
+192,933
| New | +$18M | 0.85% | 49 |
|